Company Monitoring Page for Sanofi

latest headlines for company on cafepharma

Sanofi sees midphase success in multiple sclerosis decades after safety concerns scuttled peers
Fierce Biotech
Wed, 05/31/23 - 10:54 am
Tags:
Sanofi, MS, multiple sclerosis, clinical trials, frexalimab
Go or no go? Key FDA decisions for Argenx and Regeneron
EP Vantage
Wed, 05/31/23 - 10:51 am
Tags:
FDA, Albireo Pharma, Aldeyra Therapeutics, Alvotech, Amneal Pharmaceuticals, Argenx, ARS Pharmaceuticals, AstraZeneca, Bayer, Bio-Thera Solutions, Biogen, BioMarin Pharmaceutical, Bristol Myers Squibb, Eisai, Eton Pharmaceuticals, F2G, Fabre-Kramer Pharmaceuticals, Fresenius, GSK, Intercept Pharmaceuticals, Ipsen, Ironwood Pharmaceuticals, Merck, Novaliq, Pfizer, Regeneron, Roche, Sanofi, Sarepta Therapeutics, Shionogi, Swedish Orphan Biovitrum, Takeda, Teva Pharmaceutica, UCB Pharma
Sanofi, Regeneron flesh out COPD data with Dupixent
Pharmaphorum
Mon, 05/22/23 - 10:16 am
Tags:
Sanofi, Regeneron, COPD, Dupixent
Supreme Court rules against Amgen bid to revive cholesterol drug patents
KFGO/Reuters
Thu, 05/18/23 - 11:24 am
Tags:
Supreme Court, Amgen, Sanofi, Regeneron, patents, Repatha, legal
2023’s biggest launches: the story so far
EP Vantage
Fri, 05/12/23 - 10:19 am
Tags:
drug launches, AbbVie, Almirall, Apellis Pharmaceuticals, Astellas, AstraZeneca, Biogen, CRISPR Therapeutics, Daiichi Sankyo, Eli Lilly, Genmab, GSK, Iveric Bio, Pfizer, Roche, SAGE Therapeutics, Sanofi, Sarepta Therapeutics, Shionogi, Swedish Orphan Biovitrum, Vertex Pharmaceuticals
Sanofi, AstraZeneca Report Promising RSV Pediatric Data Ahead of Pfizer Adcomm
BioSpace
Fri, 05/12/23 - 10:16 am
Tags:
Sanofi, AstraZeneca, RSV, antibodies, infants, clinical trials
What you need to know about pharma, PBM execs testifying on insulin prices
Medical Marketing and Media
Wed, 05/10/23 - 11:15 pm
Tags:
PBMs, insulin, diabetes, drug pricing, Sanofi, Novo Nordisk, Eli Lilly
A blockbuster year could be building
EP Vantage
Wed, 05/10/23 - 09:55 am
Tags:
AbbVie, Amgen, AstraZeneca, Bristol Myers Squibb, Daiichi Sankyo, Eli Lilly, Gilead Sciences, Horizon Therapeutics, Merck, Moderna Therapeutics, Novartis, Novo Nordisk, Pfizer, Regeneron, Roche, Sanofi
Biogen, Novartis, Sanofi Cull Candidates in Q1 Pipeline Reprioritizations
BioSpace
Fri, 05/5/23 - 12:09 pm
Tags:
Biogen, Novartis, Sanofi, earnings, R&D
Chronic hives: Four major clinical trials to watch in 2023
Clinical Trials Arena
Wed, 05/3/23 - 11:53 am
Tags:
chronic hives, chronic urticaria, clinical trials, Sanofi, Regeneron, dupilumab, Amgen, tezepelumab, Allakos, lirentelimab, Celldex Therapeutics, barzolvolimab
Flatiron and Sanofi partner to streamline clinical trial data acquisition
Clinical Trials Arena
Tue, 05/2/23 - 10:17 am
Tags:
Flatiron Health, Sanofi, clinical trials
Sanofi strikes a $150M deal for Maze’s Pompe disease drug
BioPharma Dive
Mon, 05/1/23 - 10:10 am
Tags:
Maze Therapeutics, Pompe disease, Sanofi, MZE001
Sanofi, after $8B outlay, sees M&A strategy deliver 2 more duds
Fierce Biotech
Thu, 04/27/23 - 11:40 am
Tags:
Sanofi, M&A, earnings, Ablynx, Principia Biopharma
ALX and Sanofi partner to start Phase l/ll trial of RRMM combo therapy
Clinical Trials Arena
Wed, 04/26/23 - 10:26 am
Tags:
ALX Oncology, Sanofi, clinical trials, evorpacept, Sarclisa, relapsed or refractory multiple myeloma
Drugmakers take sides in Amgen, Regeneron fight over antibody patents
BioPharma Dive
Mon, 04/24/23 - 10:17 am
Tags:
Amgen, Regeneron Pharmaceuticals, Sanofi, Supreme Court, patents, Pfizer, Bayer, Roche, Genentech, AstraZeneca, JNJ
What spurred Lilly, Novo and Sanofi to slash insulin prices? Expert gives her take
Fierce Pharma
Fri, 04/21/23 - 10:22 am
Tags:
Novo Nordisk, Eli Lilly, Sanofi, insulin, diabetes, drug prices
Big pharma holds steady on research spending
EP Vantage
Fri, 04/21/23 - 10:03 am
Tags:
R&D, AbbVie, Amgen, AstraZeneca, Bayer, Biogen, Bristol Myers Squibb, Eli Lilly, Gilead Sciences, GSK, JNJ, Merck, Merck KGaA, Moderna Therapeutics, Novartis, Novo Nordisk, Pfizer, Regeneron, Roche, Sanofi, UCB, Vertex Pharmaceuticals
Big pharma’s biggest spenders revealed: 2022 edition
EP Vantage
Fri, 04/21/23 - 10:00 am
Tags:
M&A, R&D, AbbVie, AstraZeneca, Bristol Myers Squibb, Eli Lilly, GSK, JNJ, Merck, Novartis, Pfizer, Roche, Sanofi
AACR 2023 – Hippo makes a splash
EP Vantage
Wed, 04/19/23 - 10:07 am
Tags:
Vivace Therapeutics, VT3989, AACR, Novartis, Sanofi, Ikena Oncology
Double whammy: Supreme Court slaps down separate bids from Novartis, Sanofi
Fierce Pharma
Tue, 04/18/23 - 09:58 am
Tags:
legal, Supreme Court, Novartis, Gilenya, Sanofi, Viatris, EpiPens

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.